Literature DB >> 33745413

Viral determinants that drive Enterovirus-A71 fitness and virulence.

Pei Yi Ang1,2, Connie Wan Hui Chong1,2, Sylvie Alonso1,2.   

Abstract

Hand, Foot and Mouth Disease (HFMD) is usually a self-limiting, mild childhood disease that is caused mainly by Coxsackie virus A16 (CVA16) and Enterovirus A71 (EV-A71), both members of the Picornaviridae family. However, recurring HFMD outbreaks and epidemics due to EV-A71 infection in the Western Pacific region, and the propensity of EV-A71 strains to cause severe neurological complications have made this neurotropic virus a serious public health concern in afflicted countries. High mutation rate leading to viral quasispecies combined with frequent intra- and inter-typic recombination events amongst co-circulating EV-A71 strains have contributed to the great diversity and fast evolution of EV-A71 genomes, making impossible any accurate prediction of the next epidemic strain. Comparative genome sequence analyses and mutagenesis approaches have led to the identification of a number of viral determinants involved in EV-A71 fitness and virulence. These viral determinants include amino acid residues located in the structural proteins of the virus, affecting attachment to the host cell surface, receptor binding, and uncoating events. Critical residues in non-structural proteins have also been identified, including 2C, 3A, 3C proteases and the RNA-dependent RNA polymerase. Finally, mutations altering key secondary structures in the 5' untranslated region were also found to influence EV-A71 fitness and virulence. While our current understanding of EV-A71 pathogenesis remains fragmented, these studies may help in the rational design of effective treatments and broadly protective vaccine candidates.

Entities:  

Keywords:  5’UTR; Coxsackie virus A16 (CVA16); Foot and Mouth Disease (HFMD); Hand; RNA-dependent RNA polymerase (RdRp); VP1 capsid; intertypic recombination; neurovirulence; viral quasispecies

Year:  2021        PMID: 33745413     DOI: 10.1080/22221751.2021.1906754

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


  6 in total

1.  Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.

Authors:  Jing-Yi Lin; Kuo-Feng Weng; Chih-Kuang Chang; Yu-Nong Gong; Guo-Jen Huang; Hui-Lan Lee; Yen-Cheng Chen; Chien-Chih Huang; Jia-Ying Lu; Peng-Nien Huang; Huan-Jung Chiang; Che-Min Chen; Shin-Ru Shih
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

Review 2.  Recombination in Positive-Strand RNA Viruses.

Authors:  Haiwei Wang; Xingyang Cui; Xuehui Cai; Tongqing An
Journal:  Front Microbiol       Date:  2022-05-18       Impact factor: 6.064

3.  Analysis of Coxsackievirus B5 Infections in the Central Nervous System in Brazil: Insights into Molecular Epidemiology and Genetic Diversity.

Authors:  Raiana S Machado; Francisco Gomes-Neto; Maria L Aguiar-Oliveira; Fernanda M Burlandy; Fernando N Tavares; Edson E da Silva; Ivanildo P Sousa
Journal:  Viruses       Date:  2022-04-26       Impact factor: 5.818

4.  A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.

Authors:  Tao Meng; Sek-Man Wong; Kaw-Bing Chua
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

5.  Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling.

Authors:  Rai-Hua Lai; Yen-Hung Chow; Nai-Hsiang Chung; Tsan-Chi Chen; Feng-Shiun Shie; Jyh-Lyh Juang
Journal:  Cell Death Dis       Date:  2022-04-11       Impact factor: 8.469

6.  N4-acetylcytidine regulates the replication and pathogenicity of enterovirus 71.

Authors:  Haojie Hao; Weichi Liu; Yuanjiu Miao; Li Ma; Baocheng Yu; Lishi Liu; Chunjie Yang; Kui Zhang; Zhen Chen; Jingwen Yang; Zhenhua Zheng; Bo Zhang; Fei Deng; Peng Gong; Jianhui Yuan; Zhangli Hu; Wuxiang Guan
Journal:  Nucleic Acids Res       Date:  2022-08-16       Impact factor: 19.160

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.